Timothy Alexander

Historic Germantown Launches Free Spring Events PHILADELPHIA, PA — Historic Germantown will launch a series of free public events beginning Tuesday, April 7, offering residents and visitors access t […]

InterDigital Report Examines Network Impact of Agentic AI Growth WILMINGTON, DE — InterDigital Inc. (Nasdaq: IDCC) and ABI Research have released a report examining how the rise of agentic artificial intelligence i […]

ArriVent to Present Preclinical Cancer Drug Data at AACR 2026 NEWTOWN SQUARE, PA — ArriVent BioPharma Inc. (Nasdaq: AVBP) will present preclinical data on two cancer drug candidates at the American Association f […]

Neuronetics Reports Higher Revenue, Narrows Loss, Sets 2026 Outlook MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) reported higher fourth-quarter and full-year 2025 revenue, narrowed its losses, posted positive o […]

Prelude Therapeutics to Present Breast Cancer Drug Data at AACR 2026 WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) will present preclinical data on its experimental breast cancer drug candidate at t […]

Pennsylvania Horse Racing Association Announces 2026 Event Schedule HARRISBURG, PA — The Pennsylvania Horse Racing Association announced key dates for major horse racing events across the state in 2026, highlighting r […]

WHYY To Honor Malala Yousafzai With Lifelong Learning Award PHILADELPHIA, PA — WHYY will honor Nobel Peace Prize laureate Malala Yousafzai with its Lifelong Learning Award on Tuesday, April 14, 2026, at 5:30 p […]

Vasco Electronics Launches Web-Based Translation Platform WILMINGTON, DE — Vasco Electronics announced the launch of Vasco Audience, a web-based platform that provides simultaneous translation and live t […]

Vertex Makes Tax Software Available on Oracle Marketplace KING OF PRUSSIA, PA — Vertex Inc. (Nasdaq: VERX) said Tuesday its Vertex O Series Tax Engine and Indirect Tax Accelerator for Oracle enterprise r […]

Neuronetics Appoints Dan Reuvers as CEO, Succeeding Keith Sullivan MALVERN, PA — Neuronetics Inc. (Nasdaq: STIM) said it has appointed Dan Reuvers as president and chief executive officer, effective Monday, s […]

NRx Says FDA Finds No Bioequivalence Issues in Ketamine Filing WILMINGTON, DE — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) said the U.S. Food and Drug Administration has not identified bioequivalence deficiencies in i […]

Mineralys Grants Inducement Equity Awards to New Employee RADNOR, PA — Mineralys Therapeutics Inc. (Nasdaq: MLYS) said it granted stock options and restricted stock units to a new non-executive employee on M […]

The Lake That Covers a Town and Reveals a Story The surface of Marsh Creek Lake looks almost too calm in the early morning—just a slight ripple where a kayak cuts across the water, the paddle d […]

BTCS Revises 2026 Incentive Plan to Emphasize Profitability WAYNE, PA — BTCS Inc. (Nasdaq: BTCS) said it has revised its 2026 annual performance incentive program to place greater emphasis on gross profit, s […]

Aprea Reports 2025 Results, Early Data for APR-1051 Trial DOYLESTOWN, PA — Aprea Therapeutics Inc. (Nasdaq: APRE) reported its fourth-quarter and full-year 2025 financial results and said early clinical data f […]

Annovis Reports 2025 Results, Advances Buntanetap Trials MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) reported its 2025 financial results and said it advanced late-stage clinical development of its i […]

European Patent Office Grants Palvella Patent for QTORIN Rapamycin WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) said the European Patent Office has granted a patent covering its lead product candidate QTORIN 3 […]

TCHS Brandywine Students Earn First-Ever Tech Comp Victory DOWNINGTOWN, PA — Technical College High School Brandywine students captured their first-ever Greater Philadelphia Auto Technology Competition title, w […]

Medicus Pharma to Host Business Update Call Featuring Clinical Investigator PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) announced it will host a business update webcast on Thursday, March 26, at 11:30 a.m. Eastern t […]

NRx Says FDA Will Review NRX-100 Without New Trials WILMINGTON, DE — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) said it has received written confirmation from the U.S. Food and Drug Administration s […]